We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Influenza Vaccinations Reduce Dialysis Hospitalization Rates

By Daniel Beris
Posted on 07 Dec 2016
Hemodialysis patients who skipped their influenza vaccine were significantly more likely to be hospitalized than those who were vaccinated, according to a new study.

Researchers at Fresenius Kidney Care North America (Waltham, MA, USA) conducted a study that tracked flu vaccination and hospitalization rates during three flu seasons at Fresenius Kidney Care dialysis centers, where the patients received their hemodialysis therapy. More...
These included 158,326 patients in 2013-2014; 202,793 in 2014-2015; and 220,203 in 2015-2016. The researchers then calculated hospitalization rate per patient-year and rate ratio (RR), and found that 60.1%, 75.6%, and 80.4% of the patients for each season were vaccinated, respectively.

An analysis of the results revealed that patients who skipped vaccination were 53% more likely to be hospitalized during the flu season the first year, 87% more likely to be hospitalized the second year, and 158% more likely to be hospitalized the third year. Based on these results, the researchers called for an aggressive program for promoting flu vaccination among dialysis patients. The study was presented at the annual Kidney Week meeting, held during November 2016 in Chicago (IL, USA).

“While almost everyone should be vaccinated against influenza, people with kidney failure who are on dialysis are at high risk for complications if they get sick, which is why it is vital they get the flu vaccine every year,” said lead author biostatistician Nien Chen Li, MPH, MS, MA. “We're gratified to see that our patients are increasingly choosing to be vaccinated.”

“The results of this research suggest that aggressive programs to promote flu vaccination makes a significant difference in keeping kidney patients healthy and out of the hospital,” said Frank Maddux, MS, chief medical officer and executive VP for clinical and scientific affairs at Fresenius Medical Care. “We make it easy for patients by offering the flu vaccine at the clinic where they receive their care and explaining to them why the flu shot is important to their health. More and more patients are taking advantage of these crisis-preventing vaccinations.”

Related Links:
Fresenius Kidney Care North America


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ureteral Dilatation Balloon
Dornier Equinox
New
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Schematic of approach to simulating brain shunt fluid dynamics (Photo courtesy of Haritosh Patel/Harvard SEAS)

Computational Model Accurately Simulates Shunt Performance to Prevent Repeat Surgeries

Millions of people worldwide suffer from hydrocephalus, a condition characterized by the buildup of excess cerebrospinal fluid in the brain. Treatment typically involves the surgical placement of shunts... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.